Desk›Healthcare› Bajaj Healthcare Ltd
Bajaj Healthcare Ltd
BSE 539872 · NSE BAJAJHCARE · ISIN INE411U01027 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹322.10
+0.19%
BSE close, 28 August 2026
₹1,084.27 cr
3.4 cr shares · Micro cap
₹411.34 cr
as published
61.5× · 2.43×
EPS ₹5.24 · BV ₹132.55
611.03 / 15.77
₹ cr, as filed
20
6 selected · 30%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -37.6% |
|---|---|
| Against 52-week low | +18.2% |
| Day change | +0.19% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹5.24 |
|---|---|
| Price / earnings | 61.47× |
| Price / book | 2.43× |
| Book value — derived, price ÷ P/B | ₹132.55 |
| Return on equity | 3.95% |
| Operating margin | 17.85% |
| Net margin | 8.27% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 3.95%
- ROE as published
- 3.95%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 165.63 | 13.70 | 4.13 | 17.85% | 8.27% |
| Mar-26 · Q | 153.06 | -22.85 | -6.08 | -4.97% | -14.93% |
| FY25-26 | 611.03 | 15.77 | 6.73 | 12.88% | 2.58% |
Quarter on quarter
- Revenue, quarter on quarter
- +8.2%
- Net profit, quarter on quarter
- +160.0%
- Operating margin, quarter on quarter
- +2,282 bps
Disclosure profile 20 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Concall Transcript | 1 |
| Credit Rating | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| AGM / EGM | 2 |
| General | 2 |
| Newspaper Publication | 2 |
| Analyst / Investor Meet | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| ESOP Allotment | 1 |
| Monitoring Agency | 1 |
| Other Update | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 14 |
| Total | 20 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
20 filings · 6 selected · busiest 2026-07-20
Filing rhythm · the twelve most recent
2026-07-222026-10-09
SelectedProcedural
Filings
20 in the window · 8 earlier on record
-
9 October 2026 ·
Board Meeting Intimation for Consideration Of Financial Results
Bajaj Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2026 ,inter alia, to consider and approve the un-audited financial results ....
Board Meeting / Board Meeting View filing →
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
23 September 2026 ·
Closure of Trading Window
Intimation for closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
22 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Submission of Voting Results and Scrutinizer's Report
AGM/EGM / AGM View filing →
-
21 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 33rd Annual General Meeting of the Company held on September 21, 2026
AGM/EGM / AGM View filing →
-
3 September 2026 ·
Corporate Action-Record Date For Payment Of Final Dividend
Intimation of Record Date for the payment of Final Dividend for the financial year 2025-26
Corp. Action / Record Date View filing →
-
26 August 2026 ·
Newspaper Publication
Intimation for Newspaper Publication with respect to 33rd Annual General Meeting of the Company
Company Update / Newspaper Publication View filing →
-
21 August 2026 ·
Allotment of ESOP / ESPS
Intimation of allotment of equity shares pursuant to exercise of ESOPs
Company Update / Allotment of ESOP / ESPS View filing →
-
12 August 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
The Company has received the approval from DCGI to manufacture and market Cenobamate API and Tablets
Company Update / General View filing →
-
6 August 2026 ·
-
27 July 2026 ·
Earnings Call Transcript
Transcript of Earnings Call for Q1FY27
Company Update / Earnings Call Transcript View filing →
-
22 July 2026 ·
Newspaper Publication
Intimation for Newspaper Publication
Company Update / Newspaper Publication View filing →
-
21 July 2026 ·
Analyst / Investor Meet - Outcome
Intimation for Audio Recording of Earnings Call for Q1FY27
Company Update / Analyst / Investor Meet View filing →
-
20 July 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Intimation for Grant of Employee Stock Options under Bajaj Healthcare Limited Employee Stock Option Plan 2024
Company Update / General View filing →
-
20 July 2026 ·
Press Release / Media Release
Press Release for the quarter ended June 30, 2026
Company Update / Press Release / Media Release View filing →
-
20 July 2026 ·
Compliances- Statement Of Deviation & Variation
Statement of Deviation & Variation for the quarter ended June 30, 2026
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
20 July 2026 ·
Monitoring Agency Report
Monitoring Agency Report for the quarter ended June 30, 2026
Company Update / Monitoring Agency Report View filing →
-
20 July 2026 ·
Change in Management
Continuation of directorship of Mr. Gopalakrishnan Kesavan as Non-Executive Independent Director of the Company upon attaining the age of 75 years
Company Update / Change in Management View filing →
-
20 July 2026 ·
Results-Financial Results For June 30, 2026
Financial Results for the quarter ended June 30, 2026
Result / Financial Results View filing →
-
20 July 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting held on July 20, 2026
Board Meeting / Outcome of Board Meeting View filing →
RSS feed for Bajaj Healthcare Ltd · the 50 most recent filings